Matterworks
Matterworks is pioneering the use of unstructured molecular data for predictive biology, productizing machine intelligence for direct machine interpretation of molecular-omic data through its Large Spectral Models (LSMs). Its PyxisTM platform, released in 2024, uses generative AI for complete untargeted molecular annotation, enabling a deeper understanding of biological outcomes.
Funding Round: Series A
Funding Amount:
Date: 03-Jun-2025
Investors: Lewis & Clark Partners, OMX Ventures, Pillar VC, Germin8 Ventures, Intermountain Ventures, Tarsadia
Markets: AI, Biotech
HQ: Somerville, Massachusetts, United States
Founded: 2019
Website: https://www.matterworks.ai
LinkedIn: https://www.linkedin.com/company/matterworksbio
Twitter: https://twitter.com/matterworks_bio
Crunchbase: https://www.crunchbase.com/organization/matterworks
Leave a Comment
Comments
No comments yet.